{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:05:40Z","timestamp":1791180340619,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,21]],"date-time":"2014-10-21T00:00:00Z","timestamp":1413849600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2046-4053-3-117","type":"journal-article","created":{"date-parts":[[2014,10,21]],"date-time":"2014-10-21T15:03:36Z","timestamp":1413903816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy and safety of pharmacological treatments for neuroborreliosis\u2014protocol for a systematic review"],"prefix":"10.1186","volume":"3","author":[{"given":"Rick","family":"Dersch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H","family":"Freitag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerta","family":"R\u00fccker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Rauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg J","family":"Meerpohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,21]]},"reference":[{"key":"287_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0140-6736(98)01146-5","volume":"352","author":"RB Nadelman","year":"1998","unstructured":"Nadelman RB, Wormser GP: Lyme borreliosis. Lancet. 1998, 352: 557-565. 10.1016\/S0140-6736(98)01146-5.","journal-title":"Lancet"},{"key":"287_CR2","first-page":"1338","volume":"18","author":"JJ Halperin","year":"2012","unstructured":"Halperin JJ: Lyme disease: a multisystem infection that affects the nervous system. Continuum. 2012, 18: 1338-1350.","journal-title":"Continuum"},{"key":"287_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s004150050214","volume":"245","author":"R Kaiser","year":"1998","unstructured":"Kaiser R: Neuroborreliosis. J Neurol. 1998, 245: 247-255. 10.1007\/s004150050214.","journal-title":"J Neurol"},{"key":"287_CR4","first-page":"343","volume":"263","author":"HW Pfister","year":"1987","unstructured":"Pfister HW, Einhaupl KM, Wilske B, Preac-Mursic V: Bannwarth\u2019s syndrome and the enlarged neurological spectrum of arthropod-borne borreliosis. Zentralbl Bakteriol Mikrobiol Hyg A. 1987, 263: 343-347.","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg A"},{"issue":"Pt 4","key":"287_CR5","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1093\/brain\/113.4.1207","volume":"113","author":"J Halperin","year":"1990","unstructured":"Halperin J, Luft BJ, Volkman DJ, Dattwyler RJ: Lyme neuroborreliosis. Peripheral nervous system manifestations. Brain. 1990, 113 (Pt 4): 1207-1221.","journal-title":"Brain"},{"key":"287_CR6","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00415-013-6831-4","volume":"260","author":"T Back","year":"2013","unstructured":"Back T, Grunig S, Winter Y, Bodechtel U, Guthke K, Khati D, von Kummer R: Neuroborreliosis-associated cerebral vasculitis: long-term outcome and health-related quality of life. J Neurol. 2013, 260: 1569-1575. 10.1007\/s00415-013-6831-4.","journal-title":"J Neurol"},{"key":"287_CR7","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/BF01728463","volume":"64","author":"E Schmutzhard","year":"1986","unstructured":"Schmutzhard E, Willeit J, Gerstenbrand F: Meningopolyneuritis Bannwarth with focal nodular myositis. A new aspect in Lyme borreliosis. Klin Wochenschr. 1986, 64: 1204-1208. 10.1007\/BF01728463.","journal-title":"Klin Wochenschr"},{"key":"287_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/BF00838161","volume":"240","author":"CD Reimers","year":"1993","unstructured":"Reimers CD, de Koning J, Neubert U, Preac-Mursic V, Koster JG, Muller-Felber W, Pongratz DE, Duray PH: Borrelia burgdorferi myositis: report of eight patients. J Neurol. 1993, 240: 278-283. 10.1007\/BF00838161.","journal-title":"J Neurol"},{"key":"287_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s100960050381","volume":"18","author":"HI Huppertz","year":"1999","unstructured":"Huppertz HI, Bohme M, Standaert SM, Karch H, Plotkin SA: Incidence of Lyme borreliosis in the Wurzburg region of Germany. Eur J Clin Microbiol Infect Dis. 1999, 18: 697-703. 10.1007\/s100960050381.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"287_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","volume":"17","author":"A Mygland","year":"2010","unstructured":"Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I, European Federation of Neurological S: EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010, 17: 8-16. 10.1111\/j.1468-1331.2009.02862.x. e11-14","journal-title":"Eur J Neurol"},{"key":"287_CR11","first-page":"619","volume":"46","author":"JJ Halperin","year":"1996","unstructured":"Halperin JJ, Logigian EL, Finkel MF, Pearl RA: Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology Neurology. 1996, 46: 619-627.","journal-title":"Quality Standards Subcommittee of the American Academy of Neurology Neurology"},{"key":"287_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1874205X01206010104","volume":"6","author":"V von Baehr","year":"2012","unstructured":"von Baehr V, Doebis C, Volk HD, von Baehr R: The lymphocyte transformation test for borrelia detects active lyme borreliosis and verifies effective antibiotic treatment. Open Neurol J. 2012, 6: 104-112. 10.2174\/1874205X01206010104.","journal-title":"Open Neurol J"},{"key":"287_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.7326\/0003-4819-114-4-285","volume":"114","author":"DC Zoschke","year":"1991","unstructured":"Zoschke DC, Skemp AA, Defosse DL: Lymphoproliferative responses to Borrelia burgdorferi in Lyme disease. Ann Intern Med. 1991, 114: 285-289. 10.7326\/0003-4819-114-4-285.","journal-title":"Ann Intern Med"},{"key":"287_CR14","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s00431-012-1779-4","volume":"171","author":"HI Huppertz","year":"2012","unstructured":"Huppertz HI, Bartmann P, Heininger U, Fingerle V, Kinet M, Klein R, Korenke GC, Nentwich HJ, Committee for Infectious D, Vaccinations of the German Academy for P, Adolescent H: Rational diagnostic strategies for Lyme borreliosis in children and adolescents: recommendations by the Committee for Infectious Diseases and Vaccinations of the German Academy for Pediatrics and Adolescent Health. Eur J Pediatr. 2012, 171: 1619-1624. 10.1007\/s00431-012-1779-4.","journal-title":"Eur J Pediatr"},{"key":"287_CR15","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","volume":"43","author":"GP Wormser","year":"2006","unstructured":"Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB: The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006, 43: 1089-1134. 10.1086\/508667.","journal-title":"Clin Infect Dis"},{"key":"287_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1212\/01.wnl.0000265517.66976.28","volume":"69","author":"JJ Halperin","year":"2007","unstructured":"Halperin JJ, Shapiro ED, Logigian E, Belman AL, Dotevall L, Wormser GP, Krupp L, Gronseth G, Bever CT, Quality Standards Subcommittee of the American Academy of N: Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2007, 69: 91-102. 10.1212\/01.wnl.0000265517.66976.28.","journal-title":"Neurology"},{"key":"287_CR17","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1586\/14789072.2.1.S1","volume":"2","author":"D Cameron","year":"2004","unstructured":"Cameron D, Gaito A, Harris N, Bach G, Bellovin S, Bock K, Bock S, Burrascano J, Dickey C, Horowitz R, Phillips S, Meer-Scherrer L, Raxlen B, Sherr V, Smith H, Smith P, Stricker R, ILADS Working Group: Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti-Infect Ther. 2004, 2: S1-S13.","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"287_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/003655401300077225","volume":"33","author":"K Karkkonen","year":"2001","unstructured":"Karkkonen K, Stiernstedt SH, Karlsson M: Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis. Scand J Infect Dis. 2001, 33: 259-262. 10.1080\/003655401300077225.","journal-title":"Scand J Infect Dis"},{"key":"287_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1086\/515145","volume":"28","author":"L Dotevall","year":"1999","unstructured":"Dotevall L, Hagberg L: Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis. 1999, 28: 569-574. 10.1086\/515145.","journal-title":"Clin Infect Dis"},{"key":"287_CR20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/00365540510027228","volume":"37","author":"R Borg","year":"2005","unstructured":"Borg R, Dotevall L, Hagberg L, Maraspin V, Lotric-Furlan S, Cimperman J, Strle F: Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand J Infect Dis. 2005, 37: 449-454. 10.1080\/00365540510027228.","journal-title":"Scand J Infect Dis"},{"key":"287_CR21","volume-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"DGN","year":"2012","unstructured":"DGN: S1 Leitlinie Neuroborreliose. Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. Edited by: Diener H-C, Stuttgart WC. 2012, Stuttgart: Thieme Verlag"},{"key":"287_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jrsm.1068","volume":"4","author":"B Reeves","year":"2013","unstructured":"Reeves B, Higgins J, Ramsay C, Shea B, Tugwellf P, Wellsg G: An introduction to methodological issues when including non-randomised studies in systematic reviews on the effects of interventions. Res Synth Method. 2013, 4: 11-","journal-title":"Res Synth Method"},{"key":"287_CR23","first-page":"937","volume":"274","author":"Centers for Disease Control and Prevention","year":"1995","unstructured":"Centers for Disease Control and Prevention: Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. JAMA. 1995, 274: 937-","journal-title":"JAMA"},{"key":"287_CR24","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983, 33: 1444-1452. 10.1212\/WNL.33.11.1444.","journal-title":"Neurology"},{"key":"287_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/09638288.2013.775360","volume":"36","author":"L Turner-Stokes","year":"2014","unstructured":"Turner-Stokes L, Thu A, Williams H, Casey R, Rose H, Siegert RJ: The Neurological Impairment Scale: reliability and validity as a predictor of functional outcome in neurorehabilitation. Disabil Rehabil. 2014, 36: 23-31. 10.3109\/09638288.2013.775360.","journal-title":"Disabil Rehabil"},{"key":"287_CR26","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC van Swieten","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988, 19: 604-607. 10.1161\/01.STR.19.5.604.","journal-title":"Stroke"},{"key":"287_CR27","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","year":"2011","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Edited by: Higgins JPT, Green S. 2011, The Cochrane Collaboration, Available from \n                    http:\/\/www.cochrane-handbook.org"},{"key":"287_CR28","unstructured":"Extending the Cochrane Risk of Bias tool to assess risk of bias in randomised trials with non-parallel-group designs, and non-randomised studies.\n                    http:\/\/methods.cochrane.org\/projects-developments\/extending-cochrane-risk-bias-tool-assess-risk-bias-randomised-trials-non-paral\n                    \n                  ,"},{"key":"287_CR29","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.\n                    http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\n                    \n                  ,"},{"key":"287_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2288-8-32","volume":"8","author":"JO Friedrich","year":"2008","unstructured":"Friedrich JO, Adhikari NK, Beyene J: The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study. BMC Med Res Methodol. 2008, 8: 32-10.1186\/1471-2288-8-32.","journal-title":"BMC Med Res Methodol"},{"key":"287_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","volume":"66","author":"GH Guyatt","year":"2013","unstructured":"Guyatt GH, Thorlund K, Oxman AD, Walter SD, Patrick D, Furukawa TA, Johnston BC, Karanicolas P, Akl EA, Vist G, Kunz R, Brozek J, Kupper LL, Martin SL, Meerpohl JJ, Alonso-Coello P, Christensen R, Schunemann HJ: GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes. J Clin Epidemiol. 2013, 66: 173-183. 10.1016\/j.jclinepi.2012.08.001.","journal-title":"J Clin Epidemiol"},{"key":"287_CR32","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JA Sterne","year":"2011","unstructured":"Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, Rucker G, Harbord RM, Schmid CH, Tetzlaff J, Deeks JJ, Peters J, Macaskill P, Schwarzer G, Duval S, Altman DG, Moher D, Higgins JP: Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011, 343: d4002-10.1136\/bmj.d4002.","journal-title":"BMJ"},{"key":"287_CR33","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1002\/sim.4780132313","volume":"13","author":"A Whitehead","year":"1994","unstructured":"Whitehead A, Jones NM: A meta-analysis of clinical trials involving different classifications of response into ordered categories. Stat Med. 1994, 13: 2503-2515. 10.1002\/sim.4780132313.","journal-title":"Stat Med"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-3-117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2046-4053-3-117\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-3-117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2046-4053-3-117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T20:47:53Z","timestamp":1548190073000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/2046-4053-3-117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,21]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["287"],"URL":"https:\/\/doi.org\/10.1186\/2046-4053-3-117","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,21]]},"assertion":[{"value":"25 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"117"}}